| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Investigative Ophthalmology & Visual Science, Vol 36, 1450-1458, Copyright © 1995 by Association for Research in Vision and Ophthalmology
ARTICLES AND REPORTS |
JL Berka, AJ Stubbs, DZ Wang, R DiNicolantonio, D Alcorn, DJ Campbell and SL Skinner
Department of Anatomy and Cell Biology, University of Melbourne, Parkville, Australia.
PURPOSE. An ocular renin-angiotensin system has been implicated in the proliferation of retinal blood vessels and blindness in diabetes mellitus. Its cellular basis has not been established. The objective was to identify sites of renin synthesis, secretion, and processing in eyes from humans, BALB/c mice, Sprague-Dawley rats, and a hypertensive transgenic rat model (mREN-2) that displays amplified extrarenal renin synthesis. METHODS. Paraffin sections of eyes were incubated with antisera to renin protein, prorenin, vimentin, and Muller cells. Enzyme kinetic renin assay was performed on extracts of whole eyes (excluding lens and vitreous) and comparisons made with adrenal glands and kidneys. For detection of renin mRNA, retinas were separately pooled from BALB/c and Swiss mice. RESULTS. In normal rodent and autopsy human eyes, labeling for renin, vimentin, and Muller cell protein was observed in the cytoplasm of all macroglial Muller cells, with renin labeling most obvious in endfeet closely apposed to retinal blood vessels. Prorenin labeling was not detected. Less intense renin labeling, again without prorenin, was seen in nonpigmented ciliary epithelium of rodents. In transgenic (mREN-2) rat eyes, renin and prorenin labeling of Muller cells and nonpigmented ciliary epithelium were intense. Prorenin was localized to the posterior region of Muller cells but only sparsely to endfeet in rodent retinas, and renin was present only in an active form in amounts one third that of one adrenal. Renin mRNA was readily detected. In human retina, renin was present in active and pro-forms, and the total amount was approximately one fiftieth that of adrenal. CONCLUSION. Renin is synthesized in the retina and is specifically localized to the macroglial Muller cells. Nonpigmented ciliary epithelium also contains renin. The presence of prorenin in the posterior part of the Muller cell, with active renin throughout but notably in endfeet in apposition to retinal capillaries, suggests directional processing of renin. These findings are consistent with earlier suggestions that retinal neovascularization may be associated with Muller cell dysfunction.
This article has been cited by other articles:
|
|
 |
|
  J. L. Wilkinson-Berka Prorenin and the (Pro)renin Receptor in Ocular Pathology Am. J. Pathol., December 1, 2008; 173(6): 1591 - 1594. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. W Batenburg and A. J. Danser Prorenin and the (pro)renin receptor: binding kinetics, signalling and interaction with aliskiren Journal of Renin-Angiotensin-Aldosterone System, September 1, 2008; 9(3): 181 - 184. [PDF]
|
|
|
|
 |
|
 T. Kurihara, Y. Ozawa, N. Nagai, K. Shinoda, K. Noda, Y. Imamura, K. Tsubota, H. Okano, Y. Oike, and S. Ishida Angiotensin II Type 1 Receptor Signaling Contributes to Synaptophysin Degradation and Neuronal Dysfunction in the Diabetic Retina Diabetes, August 1, 2008; 57(8): 2191 - 2198. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. deS. Senanayake, J. Drazba, K. Shadrach, A. Milsted, E. Rungger-Brandle, K. Nishiyama, S.-I. Miura, S. Karnik, J. E. Sears, and J. G. Hollyfield Angiotensin II and Its Receptor Subtypes in the Human Retina Invest. Ophthalmol. Vis. Sci., July 1, 2007; 48(7): 3301 - 3311. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. H. Jan Danser, W. W. Batenburg, and J. H. M. van Esch Prorenin and the (pro)renin receptor--an update Nephrol. Dial. Transplant., May 1, 2007; 22(5): 1288 - 1292. [Full Text] [PDF]
|
|
|
|
|
|
J. A. Phipps, J. L. Wilkinson-Berka, and E. L. Fletcher Retinal Dysfunction in Diabetic Ren-2 Rats Is Ameliorated by Treatment with Valsartan but Not Atenolol Invest. Ophthalmol. Vis. Sci., February 1, 2007; 48(2): 927 - 934. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Satofuka, A. Ichihara, N. Nagai, T. Koto, H. Shinoda, K. Noda, Y. Ozawa, M. Inoue, K. Tsubota, H. Itoh, et al. Role of Nonproteolytically Activated Prorenin in Pathologic, but Not Physiologic, Retinal Neovascularization Invest. Ophthalmol. Vis. Sci., January 1, 2007; 48(1): 422 - 429. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Kurihara, Y. Ozawa, K. Shinoda, N. Nagai, M. Inoue, Y. Oike, K. Tsubota, S. Ishida, and H. Okano Neuroprotective Effects of Angiotensin II Type 1 Receptor (AT1R) Blocker, Telmisartan, via Modulating AT1R and AT2R Signaling in Retinal Inflammation Invest. Ophthalmol. Vis. Sci., December 1, 2006; 47(12): 5545 - 5552. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Satofuka, A. Ichihara, N. Nagai, K. Yamashiro, T. Koto, H. Shinoda, K. Noda, Y. Ozawa, M. Inoue, K. Tsubota, et al. Suppression of ocular inflammation in endotoxin-induced uveitis by inhibiting nonproteolytic activation of prorenin. Invest. Ophthalmol. Vis. Sci., June 1, 2006; 47(6): 2686 - 2692. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. B. Bergman, C. J. Moravski, S. R. Edmondson, V. C. Russo, L. A. Bach, J. L. Wilkinson-Berka, and G. A. Werther Expression of the IGF System in Normal and Diabetic Transgenic (mRen-2)27 Rat Eye Invest. Ophthalmol. Vis. Sci., August 1, 2005; 46(8): 2708 - 2715. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Sarlos and J. L. Wilkinson-Berka The Renin-Angiotensin System and the Developing Retinal Vasculature Invest. Ophthalmol. Vis. Sci., March 1, 2005; 46(3): 1069 - 1077. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Wilkinson-Berka, N. S. Alousis, D. J. Kelly, and R. E. Gilbert COX-2 Inhibition and Retinal Angiogenesis in a Mouse Model of Retinopathy of Prematurity Invest. Ophthalmol. Vis. Sci., March 1, 2003; 44(3): 974 - 979. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. J. Moravski, S. L. Skinner, A. J. Stubbs, S. Sarlos, D. J. Kelly, M. E. Cooper, R. E. Gilbert, and J. L. Wilkinson-Berka The Renin-Angiotensin System Influences Ocular Endothelial Cell Proliferation in Diabetes: Transgenic and Interventional Studies Am. J. Pathol., January 1, 2003; 162(1): 151 - 160. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. J. Moravski, D. J. Kelly, M. E. Cooper, R. E. Gilbert, J. F. Bertram, S. Shahinfar, S. L. Skinner, and J. L. Wilkinson-Berka Retinal Neovascularization Is Prevented by Blockade of the Renin-Angiotensin System Hypertension, December 1, 2000; 36(6): 1099 - 1104. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Rong, J. L. Wilkinson-Berka, and S. L. Skinner Potassium control of extrarenal renin secretion in transgenic (mRen-2)27 and normal rats Am J Physiol Endocrinol Metab, October 1, 1999; 277(4): E631 - E638. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Rong, J. L. Wilkinson-Berka, and S. L. Skinner Renin in thymus, gut, hindlimb, and adrenal of (mRen-2)27 and normal rats: secretion and content studies Am J Physiol Endocrinol Metab, October 1, 1999; 277(4): E639 - E646. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Yan, R. Chen, T. Pitarresi, C. D. Sigmund, K. W. Gross, J. E. Sealey, J. H. Laragh, and D. F. Catanzaro Kidney Is the Only Source of Human Plasma Renin in 45-kb Human Renin Transgenic Mice Circ. Res., December 14, 1998; 83(12): 1279 - 1288. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Mäkimattila, P. Summanen, I. Matinlauri, M. Mäntysaari, A. Schlenzka, M. Aalto, K. Irjala, and H. Yki-Järvinen Serum total renin, an independent marker of the activity and severity of retinopathy in patients with IDDM Br. J. Ophthalmol., August 1, 1998; 82(8): 939 - 944. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
